Long-term prognosis of minimal residual disease in breast cancer patients with breast or nodal pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC)

被引：0
|
作者：
Go, Jieon
Ahn, Jee Hyun
Park, Jung Min
Choi, Soon Bo
Kim, Jee Ye
Park, Hyung Seok
Kim, Seung Il
Park, Byeong-Woo
Park, Seho
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
Neoadjuvant chemotherapy; Pathologic complete response; Minimal residual disease; Long-term survival; Breast cancer;
D O I：
10.1158/1538-7445.SABCS21-P4-07-14
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-07-14
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Nodal Disease in Breast Cancer Predicts in Breast Pathologic Complete Response
    Baldwin, X.
    Downs-Canner, S.
    Maduekwe, U. N.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S71 - S71
  • [22] Racial Difference in Outcomes in Breast Cancer Patients with Residual Nodal Disease after Neoadjuvant Chemotherapy
    Johns, C.
    Kwon, Y. S.
    Rahimi, A. S.
    Liu, Y.
    Cauble, M.
    Alluri, P. G.
    Arbab, M.
    Nwachukwu, C. R.
    Kim, N.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E186 - E186
  • [23] Lymphopenia and clinical outcomes in patients with residual nodal disease after neoadjuvant chemotherapy for breast cancer
    Gutkin, Paulina M.
    Kozak, Margaret M.
    von Eyben, Rie
    Horst, Kathleen C.
    [J]. CANCER CAUSES & CONTROL, 2020, 31 (11) : 1021 - 1026
  • [24] Lymphopenia and clinical outcomes in patients with residual nodal disease after neoadjuvant chemotherapy for breast cancer
    Paulina M. Gutkin
    Margaret M. Kozak
    Rie von Eyben
    Kathleen C. Horst
    [J]. Cancer Causes & Control, 2020, 31 : 1021 - 1026
  • [25] Survival and recurrence of breast cancer patients with pathologic complete response after neoadjuvant chemotherapy.
    Lee, Young Joo
    Ahn, Sei-Hyun
    Sohn, Byung Ho
    Lee, Jong Won
    Chung, Il Yong
    Ko, Beom Seok
    Kim, Hee Jeong
    Kim, Jisun
    Lee, Sae Byul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Pathologic Complete Response and Survival after Long-Term Follow-Up
    Guiu, S.
    Arnould, L.
    Coudert, B.
    Liegard, M.
    Mayer, F.
    Favier, L.
    Fumoleau, P.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 572S - 572S
  • [27] Prognostic significance of residual micrometastatic axillary involvement with complete pathologic breast response after neoadjuvant chemotherapy for early breast cancer
    Garcia-Torralba, Esmeralda
    Guirao Garcia, Maria Esperanza
    de la Morena Barrio, Pilar
    Ivars Rubio, Alejandra
    Garcia Martinez, Elena
    Garcia Garre, Elisa
    Marin Zafra, Gema
    Alvarez Abril, Beatriz
    Navarro Manzano, Esther
    Ayala de la Pena, Francisco
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [28] Pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) for advanced breast cancer patients with high risk for Hereditary Breast and Ovarian Cancer Syndrome (HBOC).
    Sant'Ana, Rosane Oliveira
    de Lima Silva-Fernandes, Isabelle Joyce
    dos Santos Luciano, Maria Claudia
    de Barros Silva, Paulo Goberlanio
    Alves Lima, Marcos Venicio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] Parsing Pathologic Complete Response in Patients Receiving Neoadjuvant Chemotherapy for Breast Cancer
    Morrow, Monica
    [J]. JAMA ONCOLOGY, 2016, 2 (04) : 516 - 517
  • [30] Significance of intrinsic breast cancer subtypes on the long-term prognosis after neoadjuvant chemotherapy
    Goto, Wataru
    Kashiwagi, Shinichiro
    Takada, Koji
    Asano, Yuka
    Takahashi, Katsuyuki
    Fujita, Hisakazu
    Takashima, Tsutomu
    Tomita, Shuhei
    Hirakawa, Kosei
    Ohira, Masaichi
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
12345